U.S. Physical Therapy, Inc. Stock

Equities

USPH

US90337L1089

Healthcare Facilities & Services

Market Closed - Nyse 16:00:02 2024-05-17 EDT 5-day change 1st Jan Change
106.7 USD +0.44% Intraday chart for U.S. Physical Therapy, Inc. +0.31% +14.58%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2024 * 650M 886M Sales 2025 * 678M 924M Capitalization 1.61B 2.19B
Net income 2024 * 41M 55.84M Net income 2025 * 48M 65.37M EV / Sales 2024 * 2.42 x
Net cash position 2024 * 32.94M 44.86M Net cash position 2025 * 59.26M 80.7M EV / Sales 2025 * 2.28 x
P/E ratio 2024 *
38 x
P/E ratio 2025 *
33.7 x
Employees 5,310
Yield 2024 *
1.65%
Yield 2025 *
1.68%
Free-Float 85.76%
More Fundamentals * Assessed data
Dynamic Chart
U S Physical Therapy Insider Sold Shares Worth $268,925, According to a Recent SEC Filing MT
Transcript : U.S. Physical Therapy, Inc., Q1 2024 Earnings Call, May 08, 2024
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Reports Q1 EPS $0.46, vs. Street Est of $0.56 MT
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q1 Revenue $155.7M, vs. Street Est of $153.4M MT
U.S. Physical Therapy, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
US Physical Therapy's Briotix Health Unit Acquires Industrial Injury Prevention Business for $24 Million MT
U.S. Physical Therapy, Inc. acquired Two clinic physical therapy practice. CI
U.S. Physical Therapy, Inc. acquired 50% stake in Nine-Clinic Physical Therapy And Hand Therapy Practice for $16.4 million. CI
JPMorgan Adjusts U.S. Physical Therapy's Price Target to $117 From $99, Reiterates Overweight Rating MT
US Physical Therapy Reports Change in 2024 Medicare Rate Reduction MT
U S Physical Therapy Inc /nv Insider Sold Shares Worth $274,441, According to a Recent SEC Filing MT
Barrington Ups Price Target on U.S. Physical Therapy to $122 From $120 After Strong Q4 Beat, Keeps Outperform Rating MT
Transcript : U.S. Physical Therapy, Inc., Q4 2023 Earnings Call, Feb 29, 2024
US Physical Therapy Reports Higher Q4 Results; Ups Quarterly Dividend MT
U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024 CI
More news
1 day+0.44%
1 week+0.31%
Current month+5.13%
1 month+7.70%
3 months+4.94%
6 months+25.98%
Current year+14.58%
More quotes
1 week
105.39
Extreme 105.39
108.14
1 month
99.11
Extreme 99.11
108.14
Current year
91.69
Extreme 91.69
113.63
1 year
78.08
Extreme 78.08
124.11
3 years
73.30
Extreme 73.3
131.50
5 years
45.13
Extreme 45.13
148.48
10 years
30.74
Extreme 30.736
148.48
More quotes
Managers TitleAgeSince
Chief Executive Officer 60 03-10-31
Director of Finance/CFO 61 20-11-08
Chief Operating Officer 59 21-06-30
Members of the board TitleAgeSince
Chief Executive Officer 60 03-10-31
Director/Board Member 72 05-02-22
Director/Board Member 70 07-09-05
More insiders
Date Price Change Volume
24-05-17 106.7 +0.44% 43,247
24-05-16 106.2 -1.59% 57,829
24-05-15 108 +1.48% 80,955
24-05-14 106.4 +1.36% 56,779
24-05-13 105 -1.33% 59,722

Delayed Quote Nyse, May 17, 2024 at 04:00 pm

More quotes
U.S. Physical Therapy, Inc. is engaged in physical therapy operations and provides industrial injury prevention services. The Company is engaged in physical therapy operations primarily through its subsidiary, clinic partnerships. The Company's clinics provide preventative and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, treatment for neurologically related injuries and rehabilitation of injured workers. It operates approximately 683 outpatient physical therapy clinics in 42 states. In addition to owning and operating clinics, the Company manages about 41 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The Company also has an industrial injury prevention business which provides onsite services for clients’ employees, including injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
106.7 USD
Average target price
120.5 USD
Spread / Average Target
+12.91%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW